申请人:GILEAD SCIENCES, INC.
公开号:EP2487165A1
公开(公告)日:2012-08-15
The present application provides for a compound of Formula I,
or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.
本申请提供了一种式 I 的化合物、
或其药学上可接受的盐、溶液剂和/或酯,含有此类化合物的组合物,包括施用此类化合物的治疗方法,以及包括施用此类化合物与至少一种额外治疗剂的治疗方法。